Spectropath is an imaging technology company based on research from Emory University and Georgia Tech that allows physicians to immediately recognize targeted tissues such as cancer in real time during surgery, therapeutic, or diagnostic procedures. Spectropath is the exclusive licensee of a portfolio of issued and pending patent applications covering its core technology and future pipeline for improved contrast agents.
Looking for a particular Spectropath, Inc. employee's phone or email?
The Spectropath, Inc. annual revenue was $1 million in 2026.
Spectropath, Inc. is based in Atlanta, Georgia.
The NAICS codes for Spectropath, Inc. are [334, 33, 423, 42].
The SIC codes for Spectropath, Inc. are [50, 38, 504, 384].